Cvs Health (CVS) Depreciation & Amortization (CF) (2009 - 2026)

Cvs Health has reported Depreciation & Amortization (CF) for 18 years, with the latest figure at $1.1 billion in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 3.38% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $4.6 billion (down 1.0% YoY), and the FY2025 full-year result was $4.6 billion, changed 0.2% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $1.1 billion, down from $1.1 billion in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.2 billion in Q2 2025, with the low at $1.0 billion in Q1 2023.
• Historically, Depreciation & Amortization (CF) has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) decreased 7.41% — and 2024, when it gained 13.69%.
• Cvs Health's Depreciation & Amortization (CF) stood at $1.0 billion in 2022, then climbed by 8.72% to $1.1 billion in 2023, then gained by 1.15% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then declined by 2.79% to $1.1 billion in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.